Janus Henderson Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,799,759
| Closed | -$6.99M | – | 2479 |
|
|
2024
Q4 | $6.99M | Buy |
+2,799,759
| New | +$6.99M | ﹤0.01% | 807 |
|
|
2024
Q1 | – | Sell |
-20,300
| Closed | -$21.4K | – | 2528 |
|
|
2023
Q4 | $21.4K | Sell |
20,300
-53
| -0.3% | -$56 | ﹤0.01% | 2544 |
|
|
2023
Q3 | $140K | Buy |
20,353
+30
| +0.1% | +$206 | ﹤0.01% | 2459 |
|
|
2023
Q2 | $211K | Sell |
20,323
-66
| -0.3% | -$684 | ﹤0.01% | 2426 |
|
|
2023
Q1 | $165K | Buy |
+20,389
| New | +$165K | ﹤0.01% | 2541 |
|